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ABSTRACT
Objectives: To determine prevalence of, and risk factors
for, bacterial vaginosis (BV) among herpes simplex virus
(HSV) 2 seropositive Tanzanian women at enrolment into
a randomised, placebo-controlled trial of HSV suppressive
treatment.
Methods: 1305 HSV-2 seropositive women aged 16–35
years working in bars, guesthouses and similar facilities
were interviewed, examined and tested for HIV, syphilis,
Neisseria gonorrhoeae, Chlamydia trachomatis, BV,
candidiasis and trichomoniasis. Factors associated with
BV were analysed using logistic regression to estimate
odds ratios and 95% confidence intervals.
Results: BV prevalence was 62.9%; prevalence of
Nugent score 9–10 was 16.1%. Independent risk factors
for BV were work facility type, fewer dependents,
increasing alcohol consumption, sex in the last week
(adjusted OR 2.03; 95% CI 1.57 to 2.62), using cloths or
cotton wool for menstrual hygiene, HIV (adjusted OR 1.41;
95% CI 1.09 to 1.83) and Trichomonas vaginalis infection.
There was no association between BV and the frequency
or method of vaginal cleansing. However, BV was less
prevalent among women who reported inserting sub-
stances to dry the vagina for sex (adjusted OR 0.44; 95%
CI 0.25 to 0.75).
Conclusion: BV was extremely prevalent among our
study population of HSV-2 positive female facility workers
in North-western Tanzania. Although recent sex was
associated with increased BV prevalence, vaginal drying
was associated with lower BV prevalence. Further studies
of the effects of specific practices on vaginal flora are
warranted.
Bacterial vaginosis (BV) is one of the most
common vaginal infections worldwide. It is char-
acterised by vaginal flora changes, including a
decrease in lactobacilli, particularly those that
produce hydrogen peroxide, and an increase in
anaerobic and facultative anaerobic bacteria. BV
has been associated with a variety of adverse health
outcomes, including preterm delivery,1 intrauterine
infection,1 pelvic inflammatory disease (PID)2 and
other gynaecological complications.3
BV may also increase susceptibility to HIV and
other sexually transmitted infections (STIs),4–6 and
in prospective studies BV has been associated with
the acquisition of HIV and herpes simplex virus
(HSV) type 2.7–11 BV may also facilitate HIV and
HSV-2 transmission by increasing the frequency of
genital shedding of the virus.12
The aetiology of BV remains poorly understood,
although sexual activity and vaginal hygiene
practices have been associated with BV.4 13–16
Reproductive hormones are also thought to play
a role in the regulation of vaginal flora.17 18 In sub-
Saharan Africa, the prevalence of BV is very high,
ranging from 30–51% in community based stu-
dies.6 10 A high prevalence has also been reported
among African–American women with estimates
of up to 50% in population-based surveys.19 The
reasons for this are unclear. Prevention of BV, and
any impact that this might have on reducing the
risk of HIV acquisition, will depend in part on
identification of risk factors for BV that are
susceptible to interventions.
We report on the factors associated with BV
prevalence at baseline in a cohort of women at high
risk of STI working in bars, guesthouses and
similar facilities in Tanzania. These women were
enrolled into a trial of the effect of HSV-2
suppressive treatment on HIV incidence, and on
genital HIV and HSV-2 viral shedding in women
who are HIV positive.
MATERIALS AND METHODS
Study population
A randomised, double-blind, placebo-controlled
trial of acyclovir 400 mg twice daily suppressive
treatment was conducted in women HSV-2
seropositive in the Lake Victoria region of
Tanzania. In total, 1305 women aged 16–35 years
working in bars, guesthouses and similar facilities
were enrolled in three phases from January 2004 to
May 2006. Trial procedures have been described
previously.20 Screening, enrolment and 3-monthly
follow-up visits were conducted at mobile clinics
established in 19 communities in high HIV-
transmission areas. Women were followed for 12–
30 months depending on phase of enrolment.
At screening, after informed consent, partici-
pants were tested for antibodies to HSV-2 and
HIV, and interviewed about sociodemographic
details, sexual behaviour and intravaginal practices
(IVP). Eligible women were given an appointment
to attend the mobile clinic 8–12 weeks later;
women were asked to avoid vaginal cleansing
before attending the visit. To be eligible, women
had to be HSV-2 seropositive, have no history of
epilepsy, able to give informed consent, not
planning to move out of the study site, not
breastfeeding and not pregnant or planning preg-
nancy during follow-up.
At enrolment, participants were tested for
pregnancy and were asked about recent sexual
behaviour and IVP. Women were examined for
symptoms of reproductive tract infections (RTI),
and blood and genital samples were collected.
Participants were offered syndromic management
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for any RTI diagnosed at enrolment, risk reduction counselling,
family planning and condoms.
All women, including those ineligible to enrol, were offered
free HIV voluntary counselling and testing, with onward
referral to the nearest centre providing HIV care, including
anti-retroviral treatment where appropriate.
Laboratory methods
Screening sera were tested for HSV-2 using a type-specific IgG
ELISA (Kalon Biologicals, Guildford, Surrey, UK). Screening and
enrolment sera were tested for HIV by dual ELISA (Murex HIV
Ag/Ab Combination ELISA, Murex Biotech, Dartford, UK; Uni-
FormII Ag/Ab micro ELISA system, bioMe´rieux, Basingstoke,
UK). Repeatedly discordant samples were tested by HIV-1
p24 Ag EIA (Biorad Genetic Systems, California, USA) and line
immunoassay (INNO-LIA HIV I/II, Innogenetics, Gent,
Belgium), as described previously.20 Enrolment samples were
tested for syphilis by the rapid plasma reagin (RPR) test (Omega
Diagnostics, Alva, Scotland, UK) and Treponema pallidum
particle agglutination (TPPA) assay (Fujirebio Inc, Tokyo,
Japan), and by fluorescent treponemal antibody assay (Trepo-
Spot IF, bioMe´rieux, Maray-l’Etoile, France) if RPR positive and
TPPA negative.
For BV, vaginal smears were heat-fixed and Gram-stained
then examined by light microscopy by a single reader and scored
using the Nugent criteria.21 External quality control of a random
sample of 10% of slides was performed by an external reader
(PH). Trichomonas vaginalis was diagnosed by wet preparation
and culture (InPouch TV, BioMed Diagnostics, San Jose,
California, USA). Wet preparations were examined by light
microscopy for Candida albicans spores and hyphae. Chlamydia
trachomatis and Neisseria gonorrhoeae were diagnosed by the
AmplicorCT/NG PCR assay (Roche Diagnostics Systems,
Branchburg, New Jersey, USA). N gonorrhoeae PCR-positive
samples were retested in duplicate and classified using a ‘‘two-
out-of-three’’ strategy, and an optical density >2 was used as
the cut-off for positive rather than the manufacturer’s
recommended value of >0.2.
Cervico-vaginal lavage (CVL) from all HIV positive women
were tested for HIV-1 RNA and HSV DNA by real-time PCR
using the ABI-7300 system (Applied Biosystems, Courtabeouf,
France) and manual nucleic acid extraction (Nuclisens
miniMAG bioMe´rieux, Marcy l’Etoile, France). In addition,
CVL from a random sample of 449 HIV negative women were
tested for HSV using the same method.
Statistical methods
Risk factors for BV were analysed using odds ratios (OR) and
95% confidence intervals (CI) obtained by logistic regression.
Normal and intermediate flora categories (Nugent score 0–6)
were combined to form the category ‘‘absence of BV’’.
Unclassifiable slides containing blood, mucus and/or pus were
excluded.
Potential determinants of BV infection were considered using
a conceptual framework22 with four groups: socio-economic
factors, sexual behavioural factors, IVP and menstruation, and
biological factors. Age, considered an a priori confounder, was
included in all multivariate models. An initial model included
socio-economic factors adjusted for age. Factors whose associa-
tion reached statistical significance at p,0.1 were included in a
multivariate model and those that remained independently
associated with BV (p,0.1) were retained. The association
between each determinant in the sexual behaviour group was
assessed by adding the single determinant into the multivariate
socio-economic model. Sexual behavioural factors whose
association reached significance at p,0.1 were included in a
multivariate model; those which remained significantly asso-
ciated with BV (p,0.1) were retained. Associations with factors
in the IVP group and in the biological group were assessed in the
same way. The final model was reached by excluding factors




Results at screening have been described previously.20 In total,
1305 HSV-2 seropositive women were enrolled. Excluding 22
women with unclassifiable vaginal smears, 807 (62.9%) women
had BV, 287 (22.4%) had intermediate changes on Nugent score
and 189 (14.7%) had normal flora. Among women with BV, 207
(25.7%) had a Nugent score of 9–10.
Overall, 37.1% of women were HIV seropositive, 13.8% had
evidence of active syphilis, 5.3% had gonorrhoea, 7.0% had C
trachomatis and 30.3% had trichomoniasis. HSV genital shedding
was detected in 34 (7.6%) HIV negative and 70 (14.5%) HIV
positive women. Among HIV seropositive women, 52.6% had
detectable HIV shedding.
At least one symptom of a RTI was reported by 40.3% of
women. There was no association between any reported clinical
symptom and BV prevalence, and 60.7% of women with BV
claimed to be asymptomatic. On examination, women with BV
were more likely to have a diagnosis of vaginal discharge
syndrome (OR 1.24; 95% CI 0.99 to 1.57).
Socio-economic factors and association with BV
The mean age of participants was 27.6 years (SD 4.9); 54% were
divorced, widowed or separated, and 86% had at least one child.
About half (51%) were local food handlers and 16% were bar
workers. Over half (53%) reported drinking alcohol each week.
BV was most prevalent in younger women, with 71.8% of those
aged 16–19 years having BV compared with 60.9% of those aged
over 25 years. Prevalence was highest among bar workers and
guesthouse workers (71.0% and 73.2%, respectively, compared
with 59.3% of local food handlers; table 1). A multivariate
model of socio-economic factors adjusted for age showed that
type of facility and decreasing number of dependents were
independently associated with BV.
Association of BV with sexual and other behavioural factors
The majority of women (71%) reported fewer than 10 lifetime
partners and 54% reported only 1 partner in the past 3 months.
Most participants (64%) reported never or rarely using condoms
and 38% reported having had sex in exchange for money or gifts
in the past 3 months. At enrolment, 30% were using hormonal
contraception; among those, 62% used injectable depot-
medroxyprogesterone acetate (DMPA).
On univariate analysis, BV was significantly associated with a
number of sexual risk factors, including younger sexual debut,
increasing partners in the past 3 months, increasing condom
use, paid sex in the past 3 months and sex in the past week
(table 1). After adjusting for age and socio-economic factors,
only younger age at first sex, increasing alcohol consumption
and recent sex remained independently associated with BV.
There was some evidence of an inverse association between BV
and hormonal contraception (adjusted OR 0.80; 95% CI 0.62 to
1.04).
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Association of BV with intravaginal practices
Vaginal cleansing was reported by 65% of women of whom 99%
reported hygiene to be the primary reason for cleansing and 90%
used soap and water only. The mean cleansing frequency was
2.6 times/day (range 1–7). Using vaginal lubricants, such as
petroleum jelly, during sex (wet sex) was reported by 10% of
Table 1 Association of socio-economic and behavioural factors with bacterial vaginosis (BV) infection
Factor BV prevalence n/N (%) Univariate OR (95% CI) Adjusted OR* (95% CI)
Socio-economic factors
Age (years) p = 0.02 p = 0.36
16–19 51/71 (71.8%) 1 1
20–24 191/285 (67.0%) 0.80 (0.45 to 1.41) 0.94 (0.51 to 1.73)
25–29 259/418 (62.0%) 0.64 (0.37 to 1.11) 0.76 (0.42 to 1.40)
30–35 306/509 (60.1%) 0.59 (0.34 to 1.02) 0.81 (0.44 to 1.49)
Marital status p = 0.07 p = 0.58
Married/living with partner 188/324 (58.0%) 1 1
Divorced/separated/widow 441/693 (63.6%) 1.27 (0.97 to 1.66) 1.16 (0.87 to 1.55)
Unmarried 178/266 (66.9%) 1.46 (1.04 to 2.05) 1.17 (0.78 to 1.75)
Facility type p = 0.002 p = 0.07
Local food handler 389/656 (59.3%) 1 1
Restaurant/cafe´/grocery 116/196 (59.2%) 1.00 (0.72,1.38) 0.87 (0.62,1.23)
Guesthouse 101/138 (73.2%) 1.87 (1.25 to 2.82) 1.65 (1.08 to 2.52)
Local brew seller 59/93 (63.4%) 1.19 (0.76 to 1.87) 0.96 (0.59 to 1.56)
Bar 142/200 (71.0%) 1.68 (1.19 to 2.37) 1.25 (0.86 to 1.83)
Education p = 0.82 p = 0.42
Primary or above 570/909 (62.7%) 1 1
Less than primary 237/374 (63.4%) 1.03 (0.80 to 1.32) 0.89 (0.68 to 1.18)
Literacy p = 0.09 p = 0.28
Yes 608/986 (61.7%) 1 1
No 199/297 (67.0%) 1.26 (0.96 to 1.66) 1.18 (0.87 to 1.58)
Number of dependents{ p,0.001 p = 0.003
>2 466/785 (59.4%) 1 1
1 142/224 (63.4%) 1.19 (0.87 to 1.61) 1.14 (0.82 to 1.59)
None 199/274 (72.6%) 1.82 (1.34 to 2.46) 1.68 (1.20 to 2.34)
Behavioural factors
Number of drinks per week p,0.001 p = 0.001
0 347/602 (57.6%) 1 1
1–4 192/299 (64.2%) 1.32 (0.99 to 1.76) 1.33 (0.98 to 1.81)
5–9 90/137 (65.7%) 1.41 (0.95 to 2.07) 1.47 (0.97 to 2.22)
>10 178/245 (72.7%) 1.95 (1.41 to 2.70) 1.75 (1.21 to 2.51)
Age at first sex{ p = 0.001 p = 0.009
>18 y 213/368 (57.9%) 1 1
16–17 y 276/448 (61.6%) 1.17 (0.88 to 1.55) 1.11 (0.83 to 1.49)
14–15 y 246/375 (65.6%) 1.39 (1.03 to 1.87) 1.28 (0.94 to 1.75)
,14 y 63/82 (76.8%) 2.41 (1.39 to 4.20) 2.15 (1.21 to 3.81)
No. partners in last 3 months p,0.001 p = 0.59
0 29/63 (46.0%) 1 1
1 413/690 (59.9%) 1.75 (1.04 to 2.94) 1.16 (0.66 to 2.05)
2 210/323 (65.0%) 2.18 (1.26 to 3.76) 1.28 (0.70 to 2.34)
>3 155/207 (74.9%) 3.49 (1.94 to 6.28) 1.47 (0.75 to 2.85)
Condom use{ p = 0.007 p = 0.59
Never 132/244 (54.1%) 1 1
Rarely/sometimes 359/570 (63.0%) 1.44 (1.07 to 1.96) 1.15 (0.83 to 1.60)
Often 143/209 (68.4%) 1.84 (1.25 to 2.70) 1.34 (0.87 to 2.05)
Always 172/259 (66.4%) 1.68 (1.17 to 2.41) 1.22 (0.82 to 1.83)
Sex in exchange for money or gifts
in past 3 months
p,0.001 p = 0.20
No 464/790 (58.7%) 1 1
Yes 343/493 (69.6%) 1.61 (1.27 to 2.04) 1.19 (0.91 to 1.54)
Hormonal contraception p = 0.009 p = 0.09
No 587/900 (65.2%) 1 1
Yes 220/383 (57.4%) 0.72 (0.56 to 0.92) 0.80 (0.62 to 1.04)
Sex in past 7 days p,0.001 p,0.001
No 200/393 (50.9%) 1 1
Yes 607/890 (68.2%) 2.07 (1.62 to 2.64) 1.95 (1.52 to 2.50)
*Adjusted for age, facility type, number of dependents, number of drinks per week, age at first sex, hormonal contraception and
sex in the past 7 days; {number of adults and children for whom respondent is contributing to their food and shelter; {data for age
of first sex are missing for 10 women who could not remember. Data for condom use are missing for 1 woman.
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women. Only 5% reported inserting substances such as lemon
or caustic soda to reduce lubrication during sex (dry sex).
Although asked to avoid IVP before the clinic visit, 68% of
women reported cleansing or inserting substances for sex in the
previous 24 hours. Mean time since last IVP was 9.3 hours
(range 1–24) for cleansing and 10.6 hours (4–24) for other IVP.
Most women (78%) reported using cloths for menstrual
protection; 4% reported using cotton wool.
In the univariate analysis, BV was not associated with
frequency or timing of vaginal cleansing nor the methods used
Table 2 Association of intravaginal practices (IVP) and biological factors with bacterial vaginosis (BV)
infection
Factor BV prevalence n/N (%) Univariate OR (95% CI) Adjusted OR* (95% CI)
Intravaginal practices
Vaginal cleansing{ p = 0.79; p trend = 0.34 p = 0.36; p trend = 0.10
Does not cleanse 292/451 (64.7%) 1 1
Once daily 47/74 (63.5%) 0.95 (0.57 to 1.58) 0.95 (0.56 to 1.62)
Twice daily 174/282 (61.7%) 0.88 (0.64 to 1.19) 0.78 (0.56 to 1.08)
>3 times/day 293/473 (61.9%) 0.89 (0.68 to 1.16) 0.80 (0.60 to 1.07)
Usual method of cleansing{ p = 0.39 p = 0.20
Does not cleanse 292/451 (64.7%) 1 1
Water only 86/142 (60.6%) 0.84 (0.57 to 1.23) 0.78 (0.52 to 1.18)
Soap & water 368/600 (61.3%) 0.86 (0.67 to 1.11) 0.78 (0.60 to 1.02)
Other products 60/87 (69.0%) 1.21 (0.74 to 1.98) 1.11 (0.66 to 1.87)
Insert substances for wet sex{ p = 0.23 p = 0.99
No 722/1158 (62.3%) 1 1
Yes 84/124 (67.7%) 1.27 (0.85 to 1.88) 1.00 (0.66 to 1.52)
Insert substances for dry sex{ p = 0.008 p = 0.004
No 777/1220 (63.7%) 1 1
Yes 29/62 (46.8%) 0.50 (0.30 to 0.84) 0.45 (0.26 to 0.78)
Any IVP in last 24 h{ p = 0.81; p trend = 0.81 p = 0.89; p trend = 0.99
No 254/413 (61.5%) 1 1
13–24 h ago 149/230 (64.8%) 1.15 (0.82 to 1.61) 1.05 (0.74 to 1.49)
7–12 h ago 164/255 (64.3%) 1.13 (0.82 to 1.56) 1.12 (0.80 to 1.57)
(6 h ago 240/385 (62.3%) 1.04 (0.78 to 1.38) 0.98 (0.73 to 1.33)
Menstrual hygiene{ p = 0.05 p = 0.02
Sanitary pads 135/229 (59.0%) 1 1
Cloths/underwear/sponges 623/988 (63.1%) 1.19 (0.89 to 1.59) 1.34 (0.97 to 1.85)
Cotton wool/toilet paper 39/51 (76.5%) 2.26 (1.13 to 4.55) 2.53 (1.23 to 5.24)
Last menstrual period{ p = 0.38 p = 0.40
,7 days 216/350 (61.7%) 1 1
7–13 days 197/296 (66.6%) 1.23 (0.89 to 1.71) 1.23 (0.88 to 1.74)
>14 days 382/612 (62.4%) 1.03 (0.79 to 1.35) 1.02 (0.77 to 1.36)
Biological factors
HIV p,0.001 p = 0.002
No 483/813 (59.4%) 1 1
Yes 324/470 (68.9%) 1.52 (1.19 to 1.93) 1.49 (1.16 to 1.92)
Trichomonas vaginalis{ p,0.001 p = 0.002
No 530/889 (59.6%) 1 1
Yes 274/390 (70.3%) 1.60 (1.24 to 2.06) 1.54 (1.17 to 2.01)
Neisseria gonorrhoeae{ p = 0.13 p = 0.60
No 758/1215 (62.4%) 1 1
Yes 48/67 (71.6%) 1.52 (0.88 to 2.62) 1.16 (0.65 to 2.07)
Chlamydia trachomatis{ p = 0.37 p = 0.11
No 754/1193 (63.2%) 1 1
Yes 52/89 (58.4%) 0.82 (0.53 to 1.27) 0.69 (0.44 to 1.08)
Candidiasis{ p = 0.61 p = 0.59
No 718/1145 (62.7%) 1 1
Yes 87/134 (64.9%) 1.10 (0.76 to 1.60) 1.12 (0.75 to 1.65)
HIV genital shedding1 p = 0.14 p = 0.20
No 161/223 (72.2%) 1 1
Yes 162/246 (65.9%) 0.74 (0.50 to 1.10) 0.76 (0.50 to 1.15)
HSV-2 genital shedding" p = 0.98 p = 0.77
No 513/811 (63.3%) 1 1
Yes 65/103 (63.1%) 0.99 (0.65 to 1.52) 0.93 (0.60 to 1.46)
*Adjusted for age, facility type, number of dependents, number of drinks per week, age at first sex, hormonal contraception and
sex in the past 7 days; {data for vaginal cleansing are missing for 3 women. Data for inserting substances for sex are missing for
1 woman. Data for menstrual hygiene are missing for 15 women. Date of last menstrual period could not be remembered by 25
women. Results for Neisseria gonorrhoeae and Chlamydia trachomatis missing for 1 woman. Results for Trichomonas vaginalis and
candidiasis missing for 4 women; {cleansing vagina or inserting substances for sex; 1among 469 women HIV positive; "among
914 women (445 HIV negative and 469 HIV positive).
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(table 2). In a multivariate model of IVP, adjusted for socio-
economic and sexual behavioural factors, BV was significantly
lower among women who reported ever inserting substances for
dry sex (adjusted OR 0.45; 95% CI 0.26 to 0.78), although there
was no association between BV and vaginal drying in the past
24 hours. BV was higher among women using cloths or cotton
wool for menstrual hygiene. There was a non-significant trend
towards decreased BV prevalence with increased frequency of
vaginal cleansing (adjusted p = 0.10), but no evidence of a trend
with reported time since last cleansing.
Association of BV with biological factors
On univariate analysis, BV prevalence was significantly
associated with HIV and T vaginalis infection but not with
any other STI or with HIV or HSV genital shedding (table 2).
After adjusting for socio-economic, behavioural and IVP factors,
HIV and T vaginalis remained significantly associated with BV.
Final independent risk factors for BV
In the final multivariate model, independent risk factors for BV
were facility type, having fewer dependents, increasing alcohol
consumption, recent sex, using cloths or cotton wool for
menstrual hygiene, and prevalent HIV and T vaginalis infection
(table 3). BV was inversely associated with ever inserting
substances for dry sex. Age was retained in the final model,
although it was no longer significantly associated with BV.
DISCUSSION
We report an extremely high prevalence of BV among Tanzanian
HSV-2 seropositive women working in bars, guesthouses and
similar facilities, with 63% of women having BV. Other studies in
similar populations in sub-Saharan Africa have reported BV
prevalence between 20 and 50%.5 6 8 23 24 The higher BV prevalence
observed in our study is likely to reflect the fact that our
population was HSV-2 seropositive, since a strong association
between BV and HSV-2 has been observed in many studies.5 7 23
We found BV prevalence to be independently associated with
sex in the past 7 days. Other studies have found BV to be
associated with increased sexual activity in both community
based settings and among women at high risk of STI.15 16 23
However, a prospective study of rural women in The Gambia
found no association between sexual behaviour and BV,25 and
BV has also been detected in sexually inexperienced women.19 A
recent meta-analysis found the epidemiological data to be
consistent with BV having a sexual mode of transmission,15 but
additional factors are likely to contribute to its aetiology.
Vaginal cleansing was common in our study population as
reported in a number of African studies.6 13 23 26 27 IVPs are believed
to alter the dominant flora of the vagina and, thus, increase
susceptibility to BV.14 27 28 IVP, particularly douching, has been
described as a risk factor for BV in industrialised countries.14 28 In
sub-Saharan Africa, the association between IVP and BV is
inconsistent, perhaps reflecting the heterogeneity of the techni-
ques and substances used. In a prospective study of sex workers in
Burkino Faso, vaginal cleansing was not associated with BV.23
Among family planning clinic attendees in Zimbabwe and
Uganda, vaginal cleansing was not associated with BV although
vaginal drying was associated with BV in the univariate analysis.27
Interestingly, we found BV prevalence was significantly lower
among women who reported inserting drying substances,
although that practice was relatively uncommon. Furthermore,
we found a suggestion of a trend towards decreasing BV with
increasing frequency of vaginal cleansing.
Menstrual hygiene practices have also been suggested as an
explanation for the higher prevalence of BV in sub-Saharan
Africa. BV prevalence was higher among women in our study
who used cloths or cotton wool than in those who used sanitary
pads. However, a study in Uganda found no association
between BV and using cloths for menstrual hygiene.26
Furthermore, a crossover trial in The Gambia of modern pads
and traditional cloths found BV to be slightly more frequent
when women used sanitary pads.25
Although not statistically significant, we found some
evidence of a protective effect of hormonal contraception on
BV, which is consistent with other studies.18 27 The relationship
between hormones, contraception and BV is not well-
understood. Oestrogen increases vaginal epithelial cell activity,
resulting in increased glycogen and a more favourable environ-
ment for lactobacilli.17 However, the prevalence of BV among
post-menopausal women is low despite low oestrogen levels.17
We found strong independent associations of BV with HIV
and T vaginalis. The association between BV and HIV
acquisition has been reported in several prospective studies in
sub-Saharan Africa.9 11 27 In a similar cohort in Tanzania,
women with BV at baseline had a twofold higher risk of HIV
Table 3 Final multivariate model for factors associated with bacterial
vaginosis (BV) infection
BV prevalence n/N (%) Adjusted OR* (95% CI)
Age (years) p = 0.23
16–19 51/71 (71.8%) 1
20–24 191/285 (67.0%) 0.87 (0.48 to 1.60)
25–29 259/418 (62.0%) 0.66 (0.37 to 1.20)
30–35 306/509 (60.1%) 0.73 (0.40 to 1.33)
Facility type p = 0.03
Local food handler 389/656 (59.3%) 1
Restaurant/cafe´/grocery 116/196 (59.2%) 0.90 (0.64 to 1.28)
Guesthouse 101/138 (73.2%) 1.82 (1.18 to 2.81)
Local brew seller 59/93 (63.4%) 0.92 (0.56 to 1.51)
Bar 142/200 (71.0%) 1.26 (0.85 to 1.86)
Number of dependents p = 0.001
>2 466/785 (59.4%) 1
1 142/224 (63.4%) 1.15 (0.82 to 1.60)
None 199/274 (72.6%) 1.75 (1.25 to 2.44)
Number of drinks per week p = 0.002
0 347/602 (57.6%) 1
1–4 192/299 (64.2%) 1.36 (1.00 to 1.85)
5–9 90/137 (65.7%) 1.44 (0.94 to 2.19)
>10 178/245 (72.7%) 1.76 (1.22 to 2.55)
Sex in past 7 days p,0.001
No 200/393 (50.9%) 1
Yes 607/890 (68.2%) 2.03 (1.57 to 2.62)
Inserting substances for dry sex{ p = 0.003
No 777/1220 (63.7%) 1
Yes 29/62 (46.8%) 0.44 (0.25,0.75)
Menstrual hygiene{ p = 0.02
Sanitary pads 135/229 (59.0%) 1
Cloths/underwear/sponges 623/988 (63.1%) 1.42 (1.02 to 1.95)
Cotton wool/toilet paper 39/51 (76.5%) 2.52 (1.21 to 5.25)
HIV p = 0.008
No 483/813 (59.4%) 1
Yes 324/470 (68.9%) 1.41 (1.09 to 1.83)
Trichomonas vaginalis{ p,0.001
No 530/889 (59.6%) 1
Yes 274/390 (70.3%) 1.59 (1.22 to 2.09)
*Adjusted for all variables in the table; {data for inserting substances for dry sex are
missing for 1 woman. Data for menstrual hygiene are missing for 15 women. Results
for Trichomonas vaginalis are missing for 4 women.
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seroconversion than those without BV.8 However, a trial of
presumptive STI treatment to reduce HIV acquisition showed a
marked decrease in BV without any impact on HIV,29 and HIV
infection may be associated with increased prevalence and
persistence of BV.24
There are several limitations to our analysis. This is a cross-
sectional analysis and so we cannot determine causality of the
observed associations. Residual confounding may have
remained when adjusting for self-reported risk factors, especially
sexual behaviours, which are difficult to measure accurately.
The risk factors for BV that we identified may not be
generalisable since the women in our study were at high risk
of other RTIs and all were HSV-2 positive. Although women
were asked to avoid vaginal cleansing before they attended the
clinic many reported cleansing in the past 24 hours, which
possibly reduced the accuracy of our diagnosis of BV. However,
we found no association between women’s reported time of last
cleansing and BV. Strengths of our study include a large sample
size and the use of an expert microbiology laboratory with
external quality control to diagnose BV.
Given the association of BV with HIV acquisition shown in
many studies, and the extremely high prevalence of BV in this
and other African populations, a high proportion of HIV
infections may be attributable to BV. Further research is
warranted on preventable risk factors for BV, including specific
vaginal practices that may alter the vaginal flora.
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Key messages
c Bacterial vaginosis (BV) prevalence was extremely high in this
cohort of HSV-2 positive women.
c Consistent with studies in industrialised countries and Africa,
we found strong independent associations of BV with HIV,
Trichomonas vaginalis and recent sex.
c Vaginal cleansing was very common in this cohort, but we
found no association between BV and the frequency, timing or
methods of cleansing.
c BV prevalence was significantly lower among women who
reported inserting vaginal drying substances, although that
practice was relatively uncommon.
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